Optical coherence tomography imaging of everolimus-eluting bioresorbable vascular scaffold implanted into coronary vein graft at 3-month follow-up

Eur Heart J. 2014 Sep 1;35(33):2207. doi: 10.1093/eurheartj/ehu140. Epub 2014 Apr 10.

Authors

Tomasz Roleder¹, Zofia Parma², Grzegorz Smolka², Andrzej Ochała², Wojciech Wojakowski²

Affiliations

¹ Medical University of Silesia in Katowice, 45/47 Ziolowa Street, Katowice 40-055, Poland tomaszroleder@gmail.com.
² Medical University of Silesia in Katowice, 45/47 Ziolowa Street, Katowice 40-055, Poland.

PMID: 24722807
DOI: 10.1093/eurheartj/ehu140

No abstract available

Publication types

Case Reports

MeSH terms

Absorbable Implants
Angina Pectoris / therapy*
Coronary Angiography
Coronary Occlusion / diagnostic imaging
Coronary Occlusion / therapy
Coronary Stenosis / diagnostic imaging
Coronary Stenosis / therapy
Drug-Eluting Stents
Everolimus
Humans
Immunosuppressive Agents / administration & dosage*
Male
Middle Aged
Recurrence
Sirolimus / administration & dosage
Sirolimus / analogs & derivatives*
Tissue Scaffolds*
Tomography, Optical Coherence

Substances

Immunosuppressive Agents
Everolimus
Sirolimus